CSI Market
Sign In | Register

Metagenomi Therapeutics Inc (MGX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access MGX Annual Balance Sheets →
The data below summarizes Metagenomi Therapeutics Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent120.70
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments120.00
Accounts receivable0.00
Other Receivables0.90
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.80
Total Current Assets124.47
Equipment/Property/Plant Net9.90
Long-term investments2.15
Other Assets, Noncurrent36.25
Operating Lease Right Of Use Asset33.76
Restricted Cash Noncurrent4.39
Total Assets173.70
Liabilities
Accounts Payable, Current AC2.60
Accrued Liabilities And Other Liabilities8.57
Other Liabilities, Current16.46
Total Current Liabilities27.63
Total Long-term Debt0.00
Other liabilities, Noncurrent33.50
Operating Lease Liability Current6.11
Contract With Customer Liability Current9.31
Operating Lease Liability Noncurrent33.08
Contract With Customer Liability Noncurrent1.64
Total Liabilities61.13
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock474.10
Retained Earnings / Accumulated Deficit-361.41
Accumulated Other Comprehensive Income-0.12
Other Equity-0.12
Common Stockholder's Equity112.57
Total Stockholder's Equity112.57
Liabilities & Stockholder's Equity173.70
4 historic quarters locked

Sign in to unlock the full Metagenomi Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Metagenomi Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 10, 2026
  • Source: mgx-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-342400

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.